Prosight Management, LP Quant / Systematic

Location: Dallas, TX

CIK: 0001617201 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 14, 2024

Total Value: $249M (100.0% shares, 0.0% debt)

Holdings (34)

GLPG GALAPAGOS ADR REP 13.5%

Value $33.63M Shares 827,294 Est. Cost $45.08 Unrealized —

MGTX MEIRAGTX HOLDINGS 11.4%

Value $28.44M Shares 4,050,714 Est. Cost $7.75 Unrealized -36.3%

STTK SHATTUCK LABS 8.0%

Value $19.84M Shares 2,782,797 Est. Cost $4.75 Unrealized -42.6%

MDT MEDTRONIC 7.3%

Value $18.12M Shares 220,000 Est. Cost $76.21 Unrealized -6.2%

ORIC ORIC PHARMACEUTICALS 5.8%

Value $14.52M Shares 1,578,263 Est. Cost $4.85 Unrealized +49.2%

KURA KURA ONCOLOGY 5.5%

Value $13.66M Shares 950,000 Est. Cost $11.32 Unrealized -13.1%

BCRX BIOCRYST PHARMACEUTICALS 5.4%

Value $13.37M Shares 2,232,242 Est. Cost $8.75 Unrealized -33.8%

ADCT ADC THERAPEUTICS 4.3%

Value $10.74M Shares 6,471,800 Est. Cost $2.87 Unrealized -67.9%

ABCL ABCELLERA BIOLOGICS 3.9%

Value $9.707M Shares 1,700,000 Est. Cost $7.78 Unrealized -40.5%

QDEL QUIDELORTHO 3.5%

Value $8.764M Shares 118,920 Est. Cost $85.35 Unrealized -20.8%

PCRX PACIRA BIOSCIENCES 3.5%

Value $8.719M Shares 258,424 Est. Cost $39.77 Unrealized -26.4%

MIRM MIRUM PHARMACEUTICALS 3.5%

Value $8.658M Shares 293,301 Est. Cost $23.37 Unrealized +29.5%

PRTA PROTHENA 3.3%

Value $8.341M Shares 229,539 Est. Cost $36.66 Unrealized +5.0%

OPCH OPTION CARE HEALTH 2.0%

Value $5.013M Shares 148,800 Est. Cost $30.74 Unrealized -0.0%

— GALAPAGOS ADR REP 2.0%

Value $4.878M Shares 120,000 Est. Cost $40.65 Unrealized —

NBIX NEUROCRINE BIOSCIENCES 1.9%

Value $4.73M Shares 35,900 Est. Cost $100.70 Unrealized +14.3%

UHS UNIVERSAL HEALTH SERVICES CL B 1.7%

Value $4.282M Shares 28,090 Est. Cost $135.05 Unrealized -1.3%

— GRAPHITE BIO 1.4%

Value $3.542M Shares 1,351,939 Est. Cost $2.94 Unrealized —

— KEZAR LIFE SCIENCES 1.3%

Value $3.188M Shares 3,365,333 Est. Cost $4.51 Unrealized —

NUVB NUVATION BIO CL A 1.2%

Value $3.095M Shares 2,050,000 Est. Cost $1.50 Unrealized -14.1%

KIDS ORTHOPEDIATRICS 1.2%

Value $3.088M Shares 95,000 Est. Cost $29.00 Unrealized 0.0%

PRVA PRIVIA HEALTH GROUP 1.2%

Value $3.044M Shares 132,158 Est. Cost $22.38 Unrealized 0.0%

DXCM DEXCOM 1.1%

Value $2.854M Shares 23,000 Est. Cost $112.73 Unrealized -9.4%

— MURAL ONCOLOGY 1.0%

Value $2.478M Shares 418,505 Est. Cost $5.92 Unrealized —

— PROTHENA 0.8%

Value $1.944M Shares 53,500 Est. Cost $36.34 Unrealized —

MDRX VERADIGM 0.8%

Value $1.888M Shares 180,000 Est. Cost $12.26 Unrealized 0.0%

— ORIC PHARMACEUTICALS 0.7%

Value $1.84M Shares 200,000 Est. Cost $9.20 Unrealized —

BBSI BARRETT BUSINESS SERVICES 0.6%

Value $1.505M Shares 13,000 Est. Cost $22.58 Unrealized +12.1%

ERAS ERASCA 0.5%

Value $1.277M Shares 599,458 Est. Cost $2.70 Unrealized -21.9%

SYRE SPYRE THERAPEUTICS 0.5%

Value $1.184M Shares 55,000 Est. Cost $13.78 Unrealized 0.0%

— SHOCKWAVE MEDICAL 0.4%

Value $953K Shares 5,000 Est. Cost $190.56 Unrealized —

DSGN DESIGN THERAPEUTICS 0.3%

Value $742K Shares 280,000 Est. Cost $4.66 Unrealized -50.9%

BMEA BIOMEA FUSION 0.3%

Value $624K Shares 42,991 Est. Cost $18.03 Unrealized -32.6%

ALKS ALKERMES 0.2%

Value $416K Shares 15,000 Est. Cost $26.01 Unrealized -0.1%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
GLPG	GALAPAGOS ADR REP	827,294	$33.63M	13.5%	$45.08	—	SPON ADR	36315X101
MGTX	MEIRAGTX HOLDINGS	4,050,714	$28.44M	11.4%	$7.75	-36.3%	COM	G59665102
STTK	SHATTUCK LABS	2,782,797	$19.84M	8.0%	$4.75	-42.6%	COM	82024L103
MDT	MEDTRONIC	220,000	$18.12M	7.3%	$76.21	-6.2%	SHS	G5960L103
ORIC	ORIC PHARMACEUTICALS	1,578,263	$14.52M	5.8%	$4.85	+49.2%	COM	68622P109
KURA	KURA ONCOLOGY	950,000	$13.66M	5.5%	$11.32	-13.1%	COM	50127T109
BCRX	BIOCRYST PHARMACEUTICALS	2,232,242	$13.37M	5.4%	$8.75	-33.8%	COM	09058V103
ADCT	ADC THERAPEUTICS	6,471,800	$10.74M	4.3%	$2.87	-67.9%	SHS	H0036K147
ABCL	ABCELLERA BIOLOGICS	1,700,000	$9.707M	3.9%	$7.78	-40.5%	COM	00288U106
QDEL	QUIDELORTHO	118,920	$8.764M	3.5%	$85.35	-20.8%	COM	219798105
PCRX	PACIRA BIOSCIENCES	258,424	$8.719M	3.5%	$39.77	-26.4%	COM	695127100
MIRM	MIRUM PHARMACEUTICALS	293,301	$8.658M	3.5%	$23.37	+29.5%	COM	604749101
PRTA	PROTHENA	229,539	$8.341M	3.3%	$36.66	+5.0%	SHS	G72800108
OPCH	OPTION CARE HEALTH	148,800	$5.013M	2.0%	$30.74	-0.0%	COM NEW	68404L201
—	GALAPAGOS ADR REP	120,000	$4.878M	2.0%	$40.65	—	CALL	36315X901
NBIX	NEUROCRINE BIOSCIENCES	35,900	$4.73M	1.9%	$100.70	+14.3%	COM	64125C109
UHS	UNIVERSAL HEALTH SERVICES CL B	28,090	$4.282M	1.7%	$135.05	-1.3%	CL B	913903100
—	GRAPHITE BIO	1,351,939	$3.542M	1.4%	$2.94	—	COM	38870X104
—	KEZAR LIFE SCIENCES	3,365,333	$3.188M	1.3%	$4.51	—	COM	49372L100
NUVB	NUVATION BIO CL A	2,050,000	$3.095M	1.2%	$1.50	-14.1%	COM CL A	67080N101
KIDS	ORTHOPEDIATRICS	95,000	$3.088M	1.2%	$29.00	0.0%	COM	68752L100
PRVA	PRIVIA HEALTH GROUP	132,158	$3.044M	1.2%	$22.38	0.0%	COM	74276R102
DXCM	DEXCOM	23,000	$2.854M	1.1%	$112.73	-9.4%	COM	252131107
—	MURAL ONCOLOGY	418,505	$2.478M	1.0%	$5.92	—	ORD SHS	G63365103
—	PROTHENA	53,500	$1.944M	0.8%	$36.34	—	CALL	G72800908
MDRX	VERADIGM	180,000	$1.888M	0.8%	$12.26	0.0%	COM	01988P108
—	ORIC PHARMACEUTICALS	200,000	$1.84M	0.7%	$9.20	—	CALL	68622P909
BBSI	BARRETT BUSINESS SERVICES	13,000	$1.505M	0.6%	$22.58	+12.1%	COM	068463108
ERAS	ERASCA	599,458	$1.277M	0.5%	$2.70	-21.9%	COM	29479A108
SYRE	SPYRE THERAPEUTICS	55,000	$1.184M	0.5%	$13.78	0.0%	COM NEW	00773J202
—	SHOCKWAVE MEDICAL	5,000	$953K	0.4%	$190.56	—	COM	82489T104
DSGN	DESIGN THERAPEUTICS	280,000	$742K	0.3%	$4.66	-50.9%	COM	25056L103
BMEA	BIOMEA FUSION	42,991	$624K	0.3%	$18.03	-32.6%	COM	09077A106
ALKS	ALKERMES	15,000	$416K	0.2%	$26.01	-0.1%	SHS	G01767105